Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Datasets submission for ILB_TZWAS-HiSeq_b37 - samples

ABSTRACT: Whole genome sequencing and genotyping of samples from TZWAS (Wasaamba from Tanzania)

PROVIDER: EGAD00001005014 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Datasets submission for ILB_TZPAR-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from TZPAR (Pare from Tanzania)

| EGAD00001005016 | EGA

Datasets submission for ILB_TZCHA-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from TZCHA (Chagga from Tanzania)

| EGAD00001005015 | EGA

Datasets submission for ILB_CMSBA-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from CMSBA (Semibantu from Cameroon)

| EGAD00001005013 | EGA

Datasets submission for ILB_CMBAN-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from CMBAN (Bantu from Cameroon)

| EGAD00001005012 | EGA

Datasets submission for ILB_BFMOS-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from BFMOS (Mossi from Burkina faso)

| EGAD00001005011 | EGA

Project description:Tanzania samples chloroplast whole genome sequencing

| PRJNA1393260 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Full-length TARGET-seq resolves molecular signatures of distinct genetic subclones in MPN patients [full length TARGET-seq patient samples; Figures 3,4]

Project description:We developed TARGET-seq, a single-cell genotyping and RNA-seq method, which allows accurate detection of multiple mutations within single-cells from genomic and coding DNA in parallel with whole transcriptome analysis, providing a powerful tool to link transcriptional and genetic tumor heterogeneity. Single cell whole transcriptome sequencing of Lineage-CD34+ HSPC (Hematopoietic Stem and Progenitor Cells) from patients with myeloproliferative neoplasms and normal controls using full-length TARGET-seq reveals distinct molecular signatures associated with the presence of somatic mutations in single cells as well as distinct transcriptional profiles of WT cells from patient samples as compared with normal controls.

2019-02-11 | GSE105452 | GEO

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

Project description:The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.

| 2140168 | ecrin-mdr-crc

Genotyping of Leptospira interrogans in clinical samples by target capture sequencing

Project description:Our data demonstrate the suitability of target capture technology for purifying very low quantities of Leptospira DNA from biological samples where the human genome is in vast excess. This enables deep sequencing of partial Leptospira genomes directly from clinical samples using next generation technologies and genotyping.

2022-05-23 | E-MTAB-11667 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data